{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0944-4626#drug","name":"ADYNOVATE","alternateName":"Antihemophilic Factor (Recombinant) PEGylated","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0944-4626"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA125566"}],"activeIngredient":"","administrationRoute":[],"dosageForm":"KIT","manufacturer":{"@type":"Organization","name":"Takeda Pharmaceuticals Amercia, Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"PLASMA DERIVATIVE","sameAs":["https://api.morvs.ai/drug-approval/BLA125566","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0944-4626"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T07:03:53.546Z"}}